| Application no. and date | 09172828.7 (espacenet) (Federated) (European Patent Register), 20020905 | | Patent/reg. no. and date | DK/EP 2177223, 20120307 | | Publication date | 20100421 | | Priority no. and date | US 316967 P, 20010905 | | EP pub. no. and date |
EP 2177223 20100421 | | Effective date | | | Applicant/owner | Teva Pharmaceuticals International GmbH, Schlüsselstrasse 12
8645 Jona, CH | | Applicant ref. no. | P46396DK02 | | Inventor | Blanchard, Julie, 385 chemin de la bedoule
13540 Puyricard, FR,
Maloisel, Frederick,
18a, rue Adolphe Wurtz
67000, STRASBOURG, FR,
Robin, Jean-Pierre, 2 rue de la Muse
1205 Geneve, CH,
Maissonneuve, Hervé,
22, rue Goya
85000, LA ROCHE SUR YON, FR,
Mahon, François-Xavier, 131 quai Chartrons
33000, BORDEAUX, FR | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/506 (2006.01) , A61K 31/55 (2006.01) , A61P 35/02 (2006.01) | | Title | Homoharringtonin alene eller kombineret med andre midler til anvendelse i behandling af kronisk myeloid leukæmi der er resistent eller intolerent over for proteinkinaseinhibitorer andre end STI 571 | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
